Paragon Associates & Paragon Associates II Joint Venture purchased a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 25,000 shares of the company’s stock, valued at approximately $113,000. ASP Isotopes comprises 0.3% of Paragon Associates & Paragon Associates II Joint Venture’s portfolio, making the stock its 12th biggest position.
Other institutional investors and hedge funds also recently modified their holdings of the company. Hanson & Doremus Investment Management purchased a new position in ASP Isotopes in the fourth quarter valued at about $27,000. B. Riley Wealth Advisors Inc. purchased a new position in ASP Isotopes in the third quarter valued at approximately $42,000. Avantax Advisory Services Inc. bought a new position in ASP Isotopes during the fourth quarter valued at $45,000. SVB Wealth LLC purchased a new stake in ASP Isotopes in the fourth quarter worth $49,000. Finally, Boston Financial Mangement LLC bought a new stake in shares of ASP Isotopes in the fourth quarter valued at $50,000. 16.80% of the stock is owned by hedge funds and other institutional investors.
ASP Isotopes Stock Up 12.2 %
ASPI stock opened at $4.69 on Tuesday. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The stock has a fifty day moving average of $4.99 and a 200-day moving average of $4.95. The company has a market capitalization of $334.82 million, a price-to-earnings ratio of -7.69 and a beta of 3.66. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
- Five stocks we like better than ASP Isotopes
- Most Volatile Stocks, What Investors Need to Know
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- CD Calculator: Certificate of Deposit Calculator
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- The How And Why of Investing in Oil Stocks
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI – Free Report).
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.